| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_009f7007a3eca9c3c982dd2568c33361 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N20-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06N3-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06N3-12 |
| filingDate |
2020-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c32759e48952882ea13c43e6fb7fb68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe9eecffc0b06ef39a4c4066c829bf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10fadbc385bf6842e99cf1282b5fa789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a5cfa372929758f373b9987fac191d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2e678e689356500c89db14c5c4533e0 |
| publicationDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021209478-A1 |
| titleOfInvention |
Real-World Evidence of Diagnostic Testing and Treatment Patterns in U.S. Breast Cancer Patients with Implications for Treatment Biomarkers from RNA-Sequencing Data |
| abstract |
Techniques for analysis of gene expression data contained in real world data and real word evidence for assessing biologic pathways for identifying molecular subtypes are provided. Systems and methods include, for a plurality of biological pathways, determining a pathway score using gene expression data and determining of summary score for the plurality of biological pathways. That summary score may be compared to one or more enrichment scores each associated with a pre-determined molecular subtype. A molecular subtype is determined based on that comparison. Various heuristics may be applied to filter pathways before summary scoring. |
| priorityDate |
2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |